We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.45B
AUM Growth
+$284M
Cap. Flow
-$20.5M
Cap. Flow %
-0.46%
Top 10 Hldgs %
34.33%
Holding
1,079
New
59
Increased
179
Reduced
284
Closed
85

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$30M
2
CVS icon
CVS Health
CVS
+$24.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$16.5M
4
UNH icon
UnitedHealth
UNH
+$14.5M
5
NVDA icon
NVIDIA
NVDA
+$6.26M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Healthcare 16.06%
3 Financials 12.32%
4 Consumer Discretionary 10.19%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$126B
$55.5M 1.25%
867,688
-246,133
-22% -$16.5M
DHR icon
27
Danaher
DHR
$133B
$53.8M 1.21%
252,734
-1,551
-0.6% -$328K
HPQ icon
28
HP
HPQ
$22.7B
$53.5M 1.2%
1,742,113
-2,384
-0.1% -$71.6K
OTIS icon
29
Otis Worldwide
OTIS
$26.8B
$53.4M 1.2%
600,084
+79,848
+15% +$6.73M
BSCO
30
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$52.4M 1.18%
2,548,832
+57,598
+2% +$1.19M
TJX icon
31
TJX Companies
TJX
$169B
$49M 1.1%
577,956
-7,134
-1% -$563K
MPC icon
32
Marathon Petroleum
MPC
$91.7B
$47.9M 1.07%
410,466
+353,610
+622% +$41.1M
ABT icon
33
Abbott
ABT
$175B
$46.2M 1.04%
423,793
-15,506
-4% -$1.65M
TSM icon
34
TSMC
TSM
$2.17T
$44.8M 1.01%
443,828
+49,780
+13% +$4.63M
DHI icon
35
D.R. Horton
DHI
$39.3B
$42.9M 0.96%
352,701
+801
+0.2% +$87.6K
SPY icon
36
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$41M 0.92%
92,509
-1,133
-1% -$475K
PG icon
37
Procter & Gamble
PG
$341B
$37.3M 0.84%
246,005
-2,385
-1% -$359K
JPM icon
38
JPMorgan Chase
JPM
$925B
$37M 0.83%
254,142
-29,808
-10% -$4.1M
PII icon
39
Polaris
PII
$4.13B
$36M 0.81%
297,635
-17,949
-6% -$1.98M
BSCP
40
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$35.9M 0.81%
1,783,496
-63,463
-3% -$1.29M
XOM icon
41
ExxonMobil
XOM
$652B
$35M 0.79%
326,537
-7,398
-2% -$807K
ORCL icon
42
Oracle
ORCL
$349B
$33.6M 0.75%
281,793
-1,687
-0.6% -$174K
LH icon
43
Labcorp
LH
$23.6B
$32.7M 0.73%
157,735
+1,264
+0.8% +$245K
PFE icon
44
Pfizer
PFE
$142B
$32.7M 0.73%
891,436
-769,617
-46% -$30M
MRK icon
45
Merck
MRK
$321B
$32.6M 0.73%
282,636
+9,177
+3% +$1.04M
AZO icon
46
AutoZone
AZO
$47.8B
$32M 0.72%
12,815
+2,076
+19% +$5.29M
TXN icon
47
Texas Instruments
TXN
$257B
$31.4M 0.7%
174,382
-6,162
-3% -$1.06M
GD icon
48
General Dynamics
GD
$103B
$29.9M 0.67%
138,977
-2,059
-1% -$444K
ADBE icon
49
Adobe
ADBE
$84.7B
$29.3M 0.66%
59,872
+57,001
+1,985% +$23M
HON icon
50
Honeywell
HON
$77.7B
$28.8M 0.65%
147,411
+1,125
+0.8% +$209K

Similar funds

HM Payson & Co's Q2 2023 Portfolio in Review

As of Q2 2023, HM Payson & Co held 1,079 positions worth $4.45B, up 6.8% from $4.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

HM Payson & Co's Q2 2023 filing shows 59 new, 179 increased, 284 reduced and 85 closed positions. Its largest new stake was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M. The largest sale was Pfizer, an estimated $30M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2023 buy was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M.
  • HM Payson & Co added most to Marathon Petroleum in Q2 2023, an estimated $41.1M increase.
  • HM Payson & Co's biggest Q2 2023 reduction was Pfizer, cutting an estimated $30M.
  • HM Payson & Co fully exited Vanguard Short-Term Bond ETF in Q2 2023, selling an estimated $3.44M.
  • HM Payson & Co's ten largest holdings make up 34% of its $4.45B portfolio in Q2 2023.
  • HM Payson & Co opened 59 new positions and closed 85 in Q2 2023.
  • HM Payson & Co's portfolio value rose 6.8% quarter-over-quarter to $4.45B.

Based on HM Payson & Co's 13F filing for Q2 2023, filed 17 Jul 2023.